Brain metabolite levels in remitted psychotic depression with consideration of effects of antipsychotic medication

Author:

Tani Hideaki,Moxon-Emre Iska,Forde Natalie J.,Neufeld Nicholas H.,Bingham Kathleen S.,Whyte Ellen M.,Meyers Barnett S.,Alexopoulos George S.,Hoptman Matthew J.,Rothschild Anthony J.,Uchida Hiroyuki,Flint Alastair J.,Mulsant Benoit H.,Voineskos Aristotle N.

Abstract

Abstract Background The neurobiology of psychotic depression is not well understood and can be confounded by antipsychotics. Magnetic resonance spectroscopy (MRS) is an ideal tool to measure brain metabolites non-invasively. We cross-sectionally assessed brain metabolites in patients with remitted psychotic depression and controls. We also longitudinally assessed the effects of olanzapine versus placebo on brain metabolites. Methods Following remission, patients with psychotic depression were randomized to continue sertraline + olanzapine (n = 15) or switched to sertraline + placebo (n = 18), at which point they completed an MRS scan. Patients completed a second scan either 36 weeks later, relapse, or discontinuation. Where water-scaled metabolite levels were obtained and a Point-RESolved Spectroscopy sequence was utilized, choline, myo-inositol, glutamate + glutamine (Glx), N-acetylaspartate, and creatine were measured in the left dorsolateral prefrontal cortex (L-DLPFC) and dorsal anterior cingulate cortex (dACC). An ANCOVA was used to compare metabolites between patients (n = 40) and controls (n = 46). A linear mixed-model was used to compare olanzapine versus placebo groups. Results Cross-sectionally, patients (compared to controls) had higher myo-inositol (standardized mean difference [SMD] = 0.84; 95%CI = 0.25–1.44; p = 0.005) in the dACC but not different Glx, choline, N-acetylaspartate, and creatine. Longitudinally, patients randomized to placebo (compared to olanzapine) showed a significantly greater change with a reduction of creatine (SMD = 1.51; 95%CI = 0.71–2.31; p = 0.0002) in the dACC but not glutamate + glutamine, choline, myo-inositol, and N-acetylaspartate. Conclusions Patients with remitted psychotic depression have higher myo-inositol than controls. Olanzapine may maintain creatine levels. Future studies are needed to further disentangle the mechanisms of action of olanzapine.

Funder

Canadian Institutes of Health Research

National Institute of Mental Health

Publisher

Springer Science and Business Media LLC

Subject

Behavioral Neuroscience,Psychiatry and Mental health,Cellular and Molecular Neuroscience,Neurology (clinical),Cognitive Neuroscience,Neurology,Radiology, Nuclear Medicine and imaging

Reference50 articles.

1. Albert, K. A., Hemmings, H. C., Jr., Adamo, A. I., Potkin, S. G., Akbarian, S., Sandman, C. A., Cotman, C. W., Bunney, W. E., Jr., & Greengard, P. (2002). Evidence for decreased DARPP-32 in the prefrontal cortex of patients with schizophrenia. Archives of General Psychiatry, 59(8), 705–712. https://doi.org/10.1001/archpsyc.59.8.705

2. Bingham, K. S., Calarco, N., Dickie, E. W., Alexopoulos, G. S., Butters, M. A., Meyers, B. S., Marino, P., Neufeld, N. H., Rothschild, A. J., Whyte, E. M., Mulsant, B. H., Flint, A. J., & Voineskos, A. N. (2023). The relationship of white matter microstructure with psychomotor disturbance and relapse in remitted psychotic depression. Journal of Affective Disorders, 334, 317–324. https://doi.org/10.1016/j.jad.2023.04.136

3. Brand, A., Richter-Landsberg, C., & Leibfritz, D. (1993). Multinuclear NMR studies on the energy metabolism of glial and neuronal cells. Developmental Neuroscience, 15(3–5), 289–298. https://doi.org/10.1159/000111347

4. Busatto, G. F. (2013). Structural and functional neuroimaging studies in major depressive disorder with psychotic features: a critical review. Schizophrenia Bulletin, 39(4), 776–786. https://doi.org/10.1093/schbul/sbt054

5. Chang, K., Delbello, M., Chu, W. J., Garrett, A., Kelley, R., Mills, N., Howe, M., Bryan, H., Adler, C., Eliassen, J., Spielman, D., & Strakowski, S. M. (2012). Neurometabolite effects of response to quetiapine and placebo in adolescents with bipolar depression. Journal of Child and Adolescent Psychopharmacology, 22(4), 261–268. https://doi.org/10.1089/cap.2011.0153

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3